The Helping End Addiction Long-Term (HEAL) New Innovator Award supports a postdoctoral or newly independent Early Stage Investigator of exceptional creativity who proposes novel, original and insightful research concepts with the potential to produce a major impact, test scientific paradigms, or advance key concepts on broad, important problems in biomedical research related to pain, opioid use disorder (OUD), and/or overdose (OD).
Donor Name: National Institutes of Health (NIH)
State: All States
County: All Counties
Territory: Puerto Rico, U.S. Virgin Islands, American Samoa, Northern Mariana Islands, and Guam
Type of Grant: Grant
Deadline: 05/22/2023
Size of the Grant: $1,500,000
Grant Duration: 3 years
Details:
The NIH HEAL Initiative will require a high level of coordination and sharing between investigators. It is expected that NIH HEAL Initiative awardees will cooperate and coordinate their activities after awards are made by participating in Program Director/Principal Investigator (PD/PI) meetings, including an annual HEAL Investigators Meeting, as well as other activities.
Objectives and Scope
Novel treatments for pain, opioid addiction, and overdose are crucial to addressing the ongoing opioid crisis. The development of new treatment strategies is made difficult by the extraordinary complexity of both pain and addiction, consisting of physical, emotional, and social components. As such, effective treatment will require highly innovative ideas.
The NIH Director’s New Innovator Award addresses two important goals: stimulating highly innovative research and supporting promising Early-Stage Investigators. Early-Stage Investigators may have exceptionally innovative research ideas, but not the preliminary data required to fare well in the traditional NIH peer review system. As part of NIH’s commitment to increasing opportunities for Early-Stage Investigators, it has created the NIH Director’s New Innovator Award to support outstandingly creative Early-Stage Investigators who propose highly innovative research projects with the potential for unusually high impact. This award complements ongoing efforts by the NIH and its Institutes and Centers to fund Early-Stage Investigators through R01 grants and other mechanisms.
Funding Information
- The NIH HEAL Initiative intends to commit approximately $7.2 million for approximately 3 awards in FY 2023. The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.
- The combined budget for direct costs for the three-year project period may not exceed $1,500,000. No more than $500,000 may be requested in any single year.
Eligibility Criteria
- Higher Education Institutions
- Public/State Controlled Institutions of Higher Education
- Private Institutions of Higher Education
- The following types of Higher Education Institutions are always encouraged to apply for NIH support as Public or Private Institutions of Higher Education:
- Nonprofits Other Than Institutions of Higher Education
- Nonprofits with 501(c)(3) IRS Status (Other than Institutions of Higher Education)
- Nonprofits without 501(c)(3) IRS Status (Other than Institutions of Higher Education)
- For-Profit Organizations
- Small Businesses
- For-Profit Organizations (Other than Small Businesses)
- Local Governments
- State Governments
- County Governments
- City or Township Governments
- Special District Governments
- Indian/Native American Tribal Governments (Federally Recognized)
- Indian/Native American Tribal Governments (Other than Federally Recognized)
- Federal Government
- Eligible Agencies of the Federal Government
- U.S. Territory or Possession
- Other
- Independent School Districts
- Public Housing Authorities/Indian Housing Authorities
- Native American Tribal Organizations (other than Federally recognized tribal governments)
- Faith-based or Community-based Organizations
- Regional Organizations.
For more information, visit Grants.gov.
